v3.25.2
Segment Information - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]    
Research and development $ 101,200 $ 75,473
Interest income, net (6,337) (7,180)
Net loss (120,613) (87,150)
Share based compensation expense under Company's equity incentive plans 18,395 13,443
Research and development expenses    
Segment Reporting Information [Line Items]    
Share based compensation expense under Company's equity incentive plans 7,865 7,185
General and administrative expenses    
Segment Reporting Information [Line Items]    
Share based compensation expense under Company's equity incentive plans 10,530 6,258
Reportable Segment    
Segment Reporting Information [Line Items]    
Personnel-related general and administrative 17,832 10,696
Other general and administrative 8,192 8,112
Interest income, net (6,337) (7,180)
Other segment items (274) 49
Net loss 120,613 87,150
Reportable Segment | Research and development expenses    
Segment Reporting Information [Line Items]    
Share based compensation expense under Company's equity incentive plans 7,865 7,185
Reportable Segment | General and administrative expenses    
Segment Reporting Information [Line Items]    
Share based compensation expense under Company's equity incentive plans 10,645 6,270
Endocrine diseases | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 19,329 15,913
Neurological diseases | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 20,937 18,479
Rheumatology diseases | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 8,209 0
Dermatology diseases | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 5,145 0
Other clinical and nonclinical | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 2,392 6,401
Other unallocated research and development | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development 10,685 10,160
Personnel-related research and development | Reportable Segment    
Segment Reporting Information [Line Items]    
Research and development $ 34,503 $ 24,520